Alto Neuroscience, Inc.
ANRO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61 | -$36 | -$28 | -$9 |
| Dep. & Amort. | $1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $3 | $2 | $0 |
| Change in WC | $4 | -$1 | $5 | -$1 |
| Other Non-Cash | $2 | $0 | $1 | $0 |
| Operating Cash Flow | -$47 | -$33 | -$20 | -$9 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2 | -$0 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1 | $0 | $10 | $0 |
| Stock Issued | $138 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | $68 | $34 | $32 |
| Financing Cash Flow | $136 | $68 | $44 | $32 |
| Forex Effect | -$0 | -$0 | -$0 | -$0 |
| Net Chg. in Cash | $86 | $34 | $23 | $22 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $83 | $48 | $26 | $4 |
| End Cash | $169 | $83 | $48 | $26 |
| Free Cash Flow | -$49 | -$34 | -$21 | -$10 |